These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 1618602

  • 1. The discovery and development of zileuton: an orally active 5-lipoxygenase inhibitor.
    Bell RL, Young PR, Albert D, Lanni C, Summers JB, Brooks DW, Rubin P, Carter GW.
    Int J Immunopharmacol; 1992 Apr; 14(3):505-10. PubMed ID: 1618602
    [Abstract] [Full Text] [Related]

  • 2. New Hydroxycinnamic Acid Esters as Novel 5-Lipoxygenase Inhibitors That Affect Leukotriene Biosynthesis.
    Boudreau LH, Lassalle-Claux G, Cormier M, Blanchard S, Doucet MS, Surette ME, Touaibia M.
    Mediators Inflamm; 2017 Apr; 2017():6904634. PubMed ID: 28680195
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The 5-lipoxygenase inhibitory activity of zileuton in in vitro and in vivo models of antigen-induced airway anaphylaxis.
    Malo PE, Bell RL, Shaughnessy TK, Summers JB, Brooks DW, Carter GW.
    Pulm Pharmacol; 1994 Apr; 7(2):73-9. PubMed ID: 8081074
    [Abstract] [Full Text] [Related]

  • 5. A-78773: a selective, potent 5-lipoxygenase inhibitor.
    Bell RL, Brooks DW, Young PR, Lanni C, Stewart AO, Bouska J, Malo PE, Carter GW.
    J Lipid Mediat; 1993 Apr; 6(1-3):259-64. PubMed ID: 8395248
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. High ability of zileuton ((±)-1-(1-benzo[b]thien-2-ylethyl)-1-hydroxyurea) to stimulate IK(Ca) but suppress IK(DR) and IK(M) independently of 5-lipoxygenase inhibition.
    Hung TY, Huang CW, Wu SN.
    Eur J Pharmacol; 2020 Nov 15; 887():173482. PubMed ID: 32795513
    [Abstract] [Full Text] [Related]

  • 10. [The role of leukotrienes in inflammation and leukotriene inhibitors].
    Kupczyk M, Kuna P.
    Pol Merkur Lekarski; 1999 Sep 15; 7(39):85-93. PubMed ID: 10598480
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [5-lipoxygenase inhibitors in asthma therapy].
    Tanaka R.
    Nihon Rinsho; 1996 Nov 15; 54(11):3040-4. PubMed ID: 8950951
    [Abstract] [Full Text] [Related]

  • 13. 5-lipoxygenase inhibitor zileuton attenuates ischemic brain damage: involvement of matrix metalloproteinase 9.
    Tu XK, Yang WZ, Shi SS, Chen CM, Wang CH.
    Neurol Res; 2009 Oct 15; 31(8):848-52. PubMed ID: 19309543
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Preclinical and clinical activity of zileuton and A-78773.
    Bell RL, Lanni C, Malo PE, Brooks DW, Stewart AO, Hansen R, Rubin P, Carter GW.
    Ann N Y Acad Sci; 1993 Nov 30; 696():205-15. PubMed ID: 8109828
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.